Feed NVCR
NV

NovoCure NVCR · NASDAQ

$14.68 -2.78% (-$0.42)

Market cap
$1.73B
Enterprise value
$1.87B
P/E
-
Forward P/E
-
PEG
-
P/S
2.5x
P/FCF
-
EV/EBITDA
-
ROIC
-26.2%
Bruto marža
76.1%
Neto marža
-21.2%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-
Beta
0.99
Free float
82.8%

O podjetju

NovoCure Limited is an international biotechnology company specializing in the development of innovative therapies for cancer treatment. The company is known for its unique Tumor Treating Fields (TTFields) technology, which uses electric fields to target and treat tumors, inhibiting their growth. TTFields is a non-invasive treatment that is used for various types of cancer, including brain cancer, lung cancer, and more. NovoCure focuses on providing new therapeutic approaches that can improve treatment outcomes and the quality of life for patients suffering from cancer.

Sector

Healthcare

Industry

Medical - Devices

CEO

Frank Leonard

Employees

1,605

Headquarters

Baar

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.